Illumina-Grail decision sees the European Union lean in to "innovation"

Illumina-Grail decision sees the European Union lean in to "innovation"

MLex Market Insight

In a decision that ricocheted around the world this month, the European Commission announced it had blocked the $8 billion Illumina-Grail merger. Arguing that Illumina’s acquisition of Grail, a cancer-testing company, wo…

Related tracks

See all